Tag Archives: prostate cancer

jointhemovement-one-million-strong-fight-crc

Meet the One Million Strong – Gordon C. from North Carolina

Meet the One Million Strong – Gordon C. from North Carolina

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET GORDON Gordon Cole, Survivor Greensboro, NC GORDON’S STORY Following his diagnosis of stage IV colorectal cancer in August 2003, Gordon has received radiation treatment, almost constant chemotherapy, a colon resection, two liver resections, RFA, a clinical trial (at Duke), two lung resections, and continuing maintenance chemo, along with a prostate cancer diagnosis in late ’06. He has participated in a clinical trial, and is still in treatment following a recurrence and side effects from radiation damage requiring surgeries, using his research knowledge to monitor his own treatment. He has

Should Pink October Turn Blue?

By Chris Adams, Research Advocate for Fight Colorectal Cancer Last month, you may have noticed the pink jetliners, pink NFL players and pink garbage trucks.  Yes, it was Pink October, also known as National Breast Cancer Awareness Month (NBCAM).  NBCAM is probably the biggest and most successful public awareness campaign in modern US history.  NBCAM’s goal is to increase awareness of the need to screen for breast cancer through mammograms.  Now we are in November and you may have noticed that your colleagues are sporting more facial hair than Mumford and Sons.  Yes, it is Movember or No-shavember or something, the up and coming awareness month for prostate cancer screening

Prostate Cancer Treatment Increases Risk of Colorectal Cancer

A commonly used treatment for prostate cancer may increase the risk of colorectal cancer. Older men with prostate cancer who received treatment that reduced androgen had a 30 to 40 percent higher risk of getting colorectal cancer than men who didn’t have the therapy. The longer they received the treatment, the greater their risk. Androgen deprivation therapy (ADT) is approved for treatment for men with advanced prostate cancer, but its use is controversial in older men with earlier, low-risk cancer although it is widely used in those men. The link of ADT to colorectal cancer may help lower-risk men make a decision about therapy for their prostate cancer.

Top